Ignite Creation Date:
2024-05-05 @ 11:19 AM
Last Modification Date:
2024-10-26 @ 9:03 AM
Study NCT ID:
NCT00003296
Status:
UNKNOWN
Last Update Posted:
2013-12-19
First Post:
1999-11-01
Brief Title:
Liposomal Doxorubicin in Treating Patients With Liver or Bile Duct Cancer
Sponsor:
Brown University
Organization:
National Cancer Institute NCI
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Liver Cancer |
| Extrahepatic Bile Duct Cancer |
| Gallbladder Cancer |
Keywords:
| Name | View |
|---|---|
| adult primary cholangiocellular carcinoma | View |
| localized resectable adult primary liver cancer | View |
| localized unresectable adult primary liver cancer | View |
| advanced adult primary liver cancer | View |
| recurrent adult primary liver cancer | View |
| localized gallbladder cancer | View |
| unresectable gallbladder cancer | View |
| recurrent gallbladder cancer | View |
| localized extrahepatic bile duct cancer | View |
| unresectable extrahepatic bile duct cancer | View |
| recurrent extrahepatic bile duct cancer | View |
| adult primary hepatocellular carcinoma | View |
| cholangiocarcinoma of the gallbladder | View |
| cholangiocarcinoma of the extrahepatic bile duct | View |